P Frings-Meuthen1, G Bernhardt2,3, J Buehlmeier2,4, N Baecker2,5, F May2, M Heer2,5. 1. German Aerospace Center (DLR), Institute of Aerospace Medicine, 51147, Cologne, Germany. petra.frings-meuthen@dlr.de. 2. German Aerospace Center (DLR), Institute of Aerospace Medicine, 51147, Cologne, Germany. 3. Novartis AG, Basel, Switzerland. 4. University Hospital Essen, University of Duisburg-Essen, Essen, Germany. 5. Department of Nutrition and Food Science, University of Bonn, Bonn, Germany.
Abstract
Potassium bicarbonate was administrated to an already alkaline diet in seven male subjects during a 21-day bed rest study and was able to decrease bed rest induced increased calcium excretion but failed to prevent bed rest-induced bone resorption. INTRODUCTION: Supplementation with alkali salts appears to positively influence calcium and bone metabolism and, thus, could be a countermeasure for population groups with an increased risk for bone loss. However, the extent to which alkalization counteracts acid-induced bone resorption or whether it merely has a calcium and bone maintenance effect is still not completely understood. In the present study, we hypothesized that additional alkalization to an already alkaline diet can further counteract bed rest-induced bone loss. METHODS: Seven healthy male subjects completed two parts of a crossover designed 21-day bed rest study: bed rest only (control) and bed rest supplemented with 90 mmol potassium bicarbonate (KHCO3) daily. RESULTS: KHCO3supplementation during bed rest resulted in a more alkaline status compared to the control intervention, demonstrated by the increase in pH and buffer capacity level (pH p = 0.023, HCO3p = 0.02, ABE p = 0.03). Urinary calcium excretion was decreased during KHCO3 supplementation (control 6.05 ± 2.74 mmol/24 h; KHCO3 4.87 ± 2.21 mmol/24 h, p = 0.03); whereas, bone formation was not affected by additional alkalization (bAP p = 0.58; PINP p = 0.60). Bone resorption marker UCTX tended to be lower during alkaline supplementation (UCTX p = 0.16). CONCLUSIONS: The more alkaline acid-base status, achieved by KHCO3 supplementation, reduced renal calcium excretion during bed rest, but was not able to prevent immobilization-induced bone resorption. However, advantages of alkaline salts on bone metabolism may occur under acidic metabolic conditions or with respect to the positive effect of reduced calcium excretion within a longer time frame. TRIAL REGISTRATION: Trial number: NCT01509456.
Potassium bicarbonate was administrated to an already alkaline diet in seven male subjects during a 21-day bed rest study and was able to decrease bed rest induced increased calcium excretion but failed to prevent bed rest-induced bone resorption. INTRODUCTION: Supplementation with alkali salts appears to positively influence calcium and bone metabolism and, thus, could be a countermeasure for population groups with an increased risk for bone loss. However, the extent to which alkalization counteracts acid-induced bone resorption or whether it merely has a calcium and bone maintenance effect is still not completely understood. In the present study, we hypothesized that additional alkalization to an already alkaline diet can further counteract bed rest-induced bone loss. METHODS: Seven healthy male subjects completed two parts of a crossover designed 21-day bed rest study: bed rest only (control) and bed rest supplemented with 90 mmol potassium bicarbonate (KHCO3) daily. RESULTS:KHCO3supplementation during bed rest resulted in a more alkaline status compared to the control intervention, demonstrated by the increase in pH and buffer capacity level (pH p = 0.023, HCO3p = 0.02, ABE p = 0.03). Urinary calcium excretion was decreased during KHCO3 supplementation (control 6.05 ± 2.74 mmol/24 h; KHCO3 4.87 ± 2.21 mmol/24 h, p = 0.03); whereas, bone formation was not affected by additional alkalization (bAP p = 0.58; PINP p = 0.60). Bone resorption marker UCTX tended to be lower during alkaline supplementation (UCTX p = 0.16). CONCLUSIONS: The more alkaline acid-base status, achieved by KHCO3 supplementation, reduced renal calcium excretion during bed rest, but was not able to prevent immobilization-induced bone resorption. However, advantages of alkaline salts on bone metabolism may occur under acidic metabolic conditions or with respect to the positive effect of reduced calcium excretion within a longer time frame. TRIAL REGISTRATION: Trial number: NCT01509456.
Entities:
Keywords:
Bed rest; Bone metabolism; Calcium excretion; Potassium bicarbonate
Authors: Susan A New; Helen M MacDonald; Marion K Campbell; James C Martin; Mark J Garton; Simon P Robins; David M Reid Journal: Am J Clin Nutr Date: 2004-01 Impact factor: 7.045
Authors: Neil A Segal; James C Torner; Mei Yang; Jeffrey R Curtis; David T Felson; Michael C Nevitt Journal: J Clin Densitom Date: 2008-05-05 Impact factor: 2.617
Authors: Lisa Ceglia; Susan S Harris; Steven A Abrams; Helen M Rasmussen; Gerard E Dallal; Bess Dawson-Hughes Journal: J Clin Endocrinol Metab Date: 2008-12-02 Impact factor: 5.958
Authors: Naina Sinha Gregory; Rekha Kumar; Emily M Stein; Ellen Alexander; Paul Christos; Richard S Bockman; John S Rodman Journal: Endocr Pract Date: 2015-09-24 Impact factor: 3.443